Dynamics of humanin release and consumption of amino acids by differentiating C2C12 myoblasts

Cover Page

Cite item


In the differentiating culture of myoblasts, the formation of myofibrils is accompanied by the consumption of amino acids and the release of their derivatives into the medium. The enhancement of mitochondrial metabolism precedes the formation of myofibrils. In this work, the release of a humanin-like peptide (HNLP, mt-RNR-peptide) and amino acid derivatives into the medium was studied in the differentiation of C2C12 myoblasts. Cells of the C2C12 line were cultured using standard techniques in plates with control of myofibril formation and samples selection for analysis at 0 (induction), 2, 4, 7, 9 and 11 days of differentiation. HNLP was determined by enzyme immunoassay, and amino acids and their metabolites by liquid chromatography. From the essential amino acids, branched chain - Val, Leu, Ile were most intensively consumed up to day 7 of differentiation. There was observed a mutual correlation between the daily production of arginine derivatives - homoarginine (hArg) and ornithine (r = 0.53, p = 0.008) with a maximum on day 2, a significant decrease of hArg production on day 4 and trace secretion after day 7. The release of HNLP, unlike hArg, lasts up to 4 days. Secretion of HNLP in course differentiating myoblasts is an early marker of the mitochondrial metabolism development. Its decrease by day 7 is associated to inhibition of the further existence of already differentiated myocytes. The early stage of cell culture differentiation is more clearly checked not by the level of essential amino acids intake, which presented in the cultivation medium at high concentrations, but by the formation of amino acid products of specialized metabolic pathways, including hArg and ornithine. The metabolic activity of mitochondria is confirmed by the secretion of HNLP. The specific functional activity of myocytes depends on the metabolic activity of the mitochondria, which can be checked without violating the integrity of the culture, according to the level of secreted HNLP.

Full Text

Restricted Access

About the authors

A. A Zhloba

I.P. Pavlov First Saint Petersburg State Medical University

Email: zhloba@mail.spbnit.ru

T. F Subbotina

I.P. Pavlov First Saint Petersburg State Medical University

N. A Smolina

V.A. Almazov National Medical Research Centre

A. A Kostareva

V.A. Almazov National Medical Research Centre


  1. Lewis M.R., Lewis W.H. Mitochondria in tissue culture. Science. New Series 1914; 39(1000): 330-3.
  2. Fujioka H., Tandler B., Consolo M.C. et al. Division of mitochondria in cultured human fibroblasts. Microscopy research and technique 2013; 76: 1213-6.
  3. Carrillo-Cocom L.M., Genel-Rey T., Araiz-Hernândez D. et al. Amino acid consumption in naïve and recombinant CHO cell cultures: producers of a monoclonal antibody. Cytotechnology 2015; 67(5): 809-20.
  4. Salazar A., Keusgen M., von Hagen J. Amino acids in the cultivation of mammalian cells. Amino Acids 2016; 48: 1161-71.
  5. Hong P., Wheat T.E., Mazzeo J.R. et al. Monitoring cell culture media with the Waters amino acid analysis solution. Waters APPlications Notebook; 2007, http://www.waters.com/webassets/cms/library/docs/720002381en.pdf.
  6. Lee C., Yen K., Cohen P. Humanin: a harbinger of mitochondrial-derived peptides? Trends Endocrinol. Metab. 2013; 24(5): 222-8.
  7. Luciano F., Zhai D., Zhu X. et al. Cytoprotective peptide humanin binds and inhibits proapoptotic bcl-2/bax family protein bimEL. J. Biol. Chem. 2005; 280: 15825-35.
  8. Remor A.P., de Matos F.J., Ghisoni K. et al. Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products. Biochim. Biophys. Acta. 2011; 1812(11): 1460-71.
  9. Bodzioch M., Lapicka-Bodzioch K., Zapala B. et al. Evidence for potential functionality of nuclearly-encoded humanin isoforms. Genomics 2009; 94(4): 247-56.
  10. Биоинформационная база данных Uniprot [Электронный ресурс]. Available at: http://www.uniprot.org/uniprot/Q8IVG9 (accessed 23 may 2018).
  11. Yaffe D., Saxel O. A myogenic cell line with altered serum requirements for differentiation a myogenic cell line with altered serum requirements for differentiation. Differentiation 1977; 7(3): 159-66.
  12. Niikura T., Sidahmed E., Hirata-Fukae C. et al. A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice. PLoS ONE. 2011; 6(1): e16259.
  13. Oh Y.K., Bachar A.R., Zacharias D.G. et al. Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice. Atherosclerosis 2011; 219(1): 65-73.
  14. Keire P., Shearer A., Shefer G. et al. Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells. Meth. Mol. Biol. 2013; 946: 431-68.
  15. Жлоба А.А., Субботина Т.Ф., Шипаева К.А. Способ определения содержания гомоаргинина в плазме крови и других биологических жидкостях человека. Патент РФ на изобр. № 2609873. 06 февраля 2017.
  16. Burattini S., Ferri P., Battistelli M. et al. C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. Eur. J. Histochem. 2004; 48(3): 223-33.
  17. Hou Y., Hu S., Jia S. et al. Whole-body synthesis of L-homoarginine in pigs and rats supplemented with L-arginine. Amino Acids 2016; 48: 993-1001.
  18. Braissant O., Henry H., Villard A.M. et al. Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC developmental biology. 2005; 5: 9.
  19. Sandell L.L., Guan X.J., Ingram R., Tilghman S.M. Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta. PNAS USA 2003; 100(8): 4622-7.
  20. Nashine S., Cohen P., Chwa M. et al. Humanin G (HNG) protects age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from mitochondrial and cellular damage. Cell Death Dis. 2017; 8(7): e2951.
  21. Herst P.M., Rowe M.R., Carson G.M. et al. Functional mitochondria in health and disease. Front. Endocrinol. 2017; 8: 296.

Copyright (c) 2018 PJSC Human Stem Cells Institute

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 57156 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies